---

An experimental anti-cancer drug can prevent -- and even reverse -- potentially fatal cardiovascular damage in a mouse model of progeria, a rare genetic disorder that causes the most dramatic form of human premature ageing, National Institutes of Health (NIH) researchers reported today.

In a study published in the Oct. 6 early online edition of the Proceedings of the National Academy of Sciences, a team led by Francis S. Collins, M.D., Ph.D., of the National Human Genome Research Institute (NHGRI), and Elizabeth G. Nabel, M.D., director of the National Heart, Lung and Blood Institute (NHLBI), describes its effort to use transgenic mice to identify and test potential therapies for children with Hutchinson-Gilford progeria syndrome.

There currently are no treatments for progeria, which is estimated to affect about one child in 4 million. At birth, children with progeria appear normal. But soon growth slows, and the children begin to show signs of accelerated ageing, such as hair loss, wrinkled skin and loss of body fat. The most lethal damage, however, occurs within the children's major blood vessels. The children develop premature cardiovascular disease, which typically leads to death from heart attack or stroke at about the age of 13.

Building upon its past experiments in cells and mice, the NIH-led team examined the effects of an experimental cancer drug, tipifarnib, in a strain of mice genetically engineered to develop cardiovascular damage similar to that seen in progeria patients. Tipifarnib belongs to a class of drugs known as farnesyltransferase inhibitors (FTIs), which are being tested in people with myeloid leukemia, neurofibromatosis and other conditions. The team had previously found that FTI drugs could reverse structural abnormalities in skin cells taken from progeria patients and grown in the laboratory.

"This approach worked much better than we thought it would. Not only did this drug prevent these mice from developing cardiovascular disease, it reversed the damage in mice that already had disease," said the study's senior author, Dr. Collins, who is the former director of NHGRI and who continues to conduct research as a special volunteer in the Genome Technology Branch of NHGRI's Division of Intramural Research.

Researchers emphasised that more work needs to be done to determine whether FTI drugs will reverse progeria-associated cardiovascular disease in humans the same way they do in mice. In children suffering from progeria, the cardiovascular disease process often remains relatively stable until late in life, when it dramatically accelerates.
"If these drugs are found to have similar effects in children, this could mark a major breakthrough for treating this devastating disease," said NHLBI's Dr. Nabel, who was a co-author of the study. "In addition, these findings shed light on the potential role of FTI drugs to treat other forms of coronary artery disease."

In 2007, researchers led by Mark Kieran, M.D., Ph.D., at the Dana-Farber Cancer Institute in Boston launched a clinical trial of another FTI drug, lonafarnib, in 28 progeria patients, ranging in age from 3 to 15, from 16 countries. Results of that study are not expected for at least a year.

Earlier this year, in experiments involving a different type of mouse model for progeria, a group of researchers from Spain and France reported that a combination of statin and bisphosphonate drugs slowed development of the visible symptoms of aging and extended life spans in the animals. Both drugs act upon the same biological pathway as FTI drugs.

While progeria affects only a few dozen children worldwide, efforts aimed at untangling the biological roots of this rare disease may prove valuable in understanding the human aging process in general. "What we learn through studies of rare genetic disorders often has implications for more common conditions," said NHGRI Scientific Director Eric D. Green, M.D., Ph.D. "For example, a growing body of evidence indicates that all people produce small amounts of the mutant protein found in progeria patients, and that this protein may play roles in ageing or longevity."

Related Articles on Cancer

1. Bone density test
   
2. Gastric Cancer
   
3. 10 Options in Treating Mesothelioma
   
4. Akt Family: Antibodies from Imgenex
   
5. Apoptosis Programmed Cell Death
   
6. Are we "Livin" or just "Survivin"?
   
7. ATM (Ataxia Telangiectasia Mutated) Antibodies from Imgenex
   
8. QuikChIP Chromatin Immunoprecipitation Kits
   
9. Epigenetic and Signal Transduction Reagents
   
10. Faces of DARPP-32: Master Signaling Mediator in the Brain?
    
11. GPR83: A Novel Treg Expressed Cell Surface Marker
    
12. New FOXP3Δ2 (Exon 2 Deleted) Specific Antibody
    
13. GPR83: A Novel Treg Expressed Cell Surface Marker
    
14. Colorectal Cancer Screening
    
15. Common Std Diseases And Cure
    
16. Diagnose Breast Cancer
    
17. How To Beat Cigarettes With Psychology
    
18. Liver Cancer Treatment, Causes And Symptoms
    
19. Pancreatic Cancer Treatment
    
20. Cancer - Causes Of Cancer And Therapies
    

Latest Articles on Cancer

1. Cancer - Causes Of Cancer And Therapies
   Prostate Cancer Kills. According to the American Cancer Association over 192,000 men will be diagnosed with prostate cancer each year. Over 27,000 men will die from this form of cancer each year. Cancer of the prostate is the second most deadly cancer for men, second only to lung cancer....
2. Pancreatic Cancer Treatment
   Pancreatic cancer is typically diagnosed after the above symptoms are either detected by the patient or the supervising doctor. After the indicators are evaluated, liver function tests and tests for CA19-9 - a marker for pancreatic cancer - are often performed. The first step in beating pancreatic cancer is empowering yourself with knowledge of how cancer works, pondering the critical thinking...
3. Liver Cancer Treatment, Causes And Symptoms
   Liver cancer also known as primary or metastasis hepatic carcinoma is a fairly rare form of cancer in the western world (1% of all cancers) but much more common in Africa and parts of Asia (10% to 50% of all cancers). It is much more prevalent in men and incidence increases with age....
4. How To Beat Cigarettes With Psychology
   Many experts believe smoking is only about 10% physical addiction and 90% psychological. Your body will recover fairly quickly from nicotine withdrawals with the worst symptoms usually subsiding in about three days or less. But your psychological dependency on cigarettes can be much more difficult to overcome....
5. Diagnose Breast Cancer
   Breast Cancer - Prevention And Cure Breast cancer, the growth of malignant cells in the breast, is the most common cancer among women. It is rare but does occur in men breast cancer usually originates in the milk carrying ducts, although it may arise in the milk producing lobules or, more rarely, in the dense connective...
6. Common Std Diseases And Cure
   We all know the importance of becoming aware of extensive ranges of sexually transmitted diseases. I have prepared a guideline of such diseases that will help everyone in getting the right cure and prevention.Sexually transmitted diseases or STD is infectious disease; it can ....
7. Anti-cancer drug fights cardiovascular disease
   An experimental anti-cancer drug can prevent -- and even reverse -- potentially fatal cardiovascular damage in a mouse model of progeria, a rare genetic disorder that causes the most dramatic form of human premature ageing, National Institutes of Health (NIH) researchers reported today. In a study published in the Oct. 6 early online edition of the Proceedings of the National Academy of Sciences...
8. Colorectal Cancer Screening
   Colorectal Cancer Screening Methods Comparison - There are five main screening methods for colorectal cancer. Digital Rectal Exam,Fecal Occult Blood Test (FOBT), Colonoscopy, Sigmoidoscopy, Double-contrast Barium Enema (DCBE). It serves as an excellent initial screening due to its safe, simple and inexpensive nature. ...
9. GPR83: A Novel Treg Expressed Cell Surface Marker
   GPR83 is a member of the Orphan-A G-Protein coupled receptor family, and has anunknown ligand. It has been previously reported in various regions of the brain, within a subset of T-lymphocytes, and by RT-PCR at low levels in heart, kidney, liver, and otherorgans. For more details read out the article:...
10. New FOXP3Δ2 (Exon 2 Deleted) Specific Antibody
    FOXP3 is a master regulator of immune homeostasis expressed specifically in CD4+ CD25+ T regulatory cells controlling their growth, development and function and generally accepted to be expressed in both mouse and human CD4+ CD25+ regulatory T cells. For more details read out the article:...

Related topics in Health & Fitness

Submit Articles © 2009 KeepArticles.com, All Rights Reserved.